Spyre Therapeutics to Participate in the 44th Annual TD Cowen Health Care Conference

WALTHAM, Mass., Feb. 26, 2024 /PRNewswire/ — Spyre Therapeutics, Inc. (NASDAQ: SYRE) (the “Company” or “Spyre”), a development-stage biotechnology company advancing best-in-class antibody engineering, rational therapeutic combinations, and precision medicine approaches for the treatment…

kSARIA Acquires Charles E. Gillman Company

NEW YORK, Feb. 26, 2024 /PRNewswire/ — kSARIA Corporation (“kSARIA” or the “Company”), a leading producer and supplier of mission-critical connectivity solutions for the aerospace and defense end markets and a portfolio company of Behrman Capital, today announced that it has acquired…

kSARIA Acquires Charles E. Gillman Company

NEW YORK, Feb. 26, 2024 /PRNewswire/ — kSARIA Corporation (“kSARIA” or the “Company”), a leading producer and supplier of mission-critical connectivity solutions for the aerospace and defense end markets and a portfolio company of Behrman Capital, today announced that it has acquired…

Citius Pharmaceuticals Announces Filing of Form S-3 Shelf Registration Statement to Replace Expiring Prior Shelf Registration

CRANFORD, N.J., Feb. 26, 2024 /PRNewswire/ — Citius Pharmaceuticals, Inc. (“Citius” or the “Company”) (Nasdaq: CTXR), a late-stage biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products, today announced that the Company filed…

Citius Pharmaceuticals Announces Filing of Form S-3 Shelf Registration Statement to Replace Expiring Prior Shelf Registration

CRANFORD, N.J., Feb. 26, 2024 /PRNewswire/ — Citius Pharmaceuticals, Inc. (“Citius” or the “Company”) (Nasdaq: CTXR), a late-stage biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products, today announced that the Company filed…

GE HealthCare and Biofourmis Collaborate to Extend Patient Monitoring Outside the Hospital with Virtual Care-at-Home Solutions

Collaboration supports the patient journey across the care continuum and eases transitions and care from the hospital to home CHICAGO and BOSTON, Feb. 26, 2024 /PRNewswire/ — GE HealthCare (Nasdaq: GEHC) and Biofourmis have announced a strategic collaboration aimed at enhancing…

GE HealthCare and Biofourmis Collaborate to Extend Patient Monitoring Outside the Hospital with Virtual Care-at-Home Solutions

Collaboration supports the patient journey across the care continuum and eases transitions and care from the hospital to home CHICAGO and BOSTON, Feb. 26, 2024 /PRNewswire/ — GE HealthCare (Nasdaq: GEHC) and Biofourmis have announced a strategic collaboration aimed at enhancing…

TECNO Unveils its Industry Bench-marking Multi-Skin Tone Color Card at MWC Barcelona 2024, Marking a Major Step-Forward in Mobile Portrait Inclusivity

BARCELONA, Spain, Feb. 26, 2024 /PRNewswire/ — Innovative technology brand TECNO officially announced its groundbreaking multi-skin tone color card at MWC Barcelona 2024. The multi-skin tone color card sets a new benchmark for multi-skin tone imaging with industry’s largest and most…

TECNO Unveils its Industry Bench-marking Multi-Skin Tone Color Card at MWC Barcelona 2024, Marking a Major Step-Forward in Mobile Portrait Inclusivity

BARCELONA, Spain, Feb. 26, 2024 /PRNewswire/ — Innovative technology brand TECNO officially announced its groundbreaking multi-skin tone color card at MWC Barcelona 2024. The multi-skin tone color card sets a new benchmark for multi-skin tone imaging with industry’s largest and most…

KEYCORP ANNOUNCES STACY L. GILBERT TO SUCCEED DOUGLAS M. SCHOSSER AS CHIEF ACCOUNTING OFFICER

CLEVELAND, Feb. 26, 2024 /PRNewswire/ — KeyCorp (NYSE: KEY) announced that Douglas M. Schosser, currently Chief Accounting Officer, will be leaving the company to pursue a senior executive position at another company, effective March 15, 2024. Stacy L. Gilbert will succeed him as…